33 results
8-K
EX-99.1
RCUS
Arcus Biosciences Inc
2 Nov 22
Arcus Biosciences Reports Third Quarter 2022 Financial Results and Provides a Pipeline Update
4:05pm
be exacerbated by the COVID-19 pandemic; Arcus’s dependence on the collaboration with Gilead for the successful development and commercialization
S-3ASR
RCUS
Arcus Biosciences Inc
11 Oct 22
Automatic shelf registration
4:50pm
and projections relating to our competitors;
our expectations as to the effect that the COVID-19 pandemic will have on our company; and
our
8-K
EX-99.1
8gd32r1 ae9
3 Aug 22
Arcus Biosciences Reports Second Quarter 2022 Financial Results and Provides a Pipeline Update
4:16pm
8-K
EX-99.1
ecanhof4
9 May 22
Results of Operations and Financial Condition
4:08pm
8-K
EX-99.1
mhwe1zkw35fv2g7vh
23 Feb 22
Arcus Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
4:08pm
8-K
EX-99.1
oa3gpf1s3hclayjil7
8 Nov 21
Arcus Biosciences Reports Third Quarter 2021 Financial Results and Provides an Update on our anti-TIGIT Domvanalimab
5:11pm
8-K
EX-99.1
x9quxb5 ay5nc34ug
5 Aug 21
Arcus Biosciences Reports Second Quarter 2021 Financial Results and Provides Operational Highlights
4:13pm
8-K
EX-99.1
k8p1 cd1p0i1nxr
5 May 21
Arcus Biosciences Reports First Quarter 2021 Financial Results and Provides Operational Highlights
4:13pm